
    \begin{table}[h]
         \centering
         \caption{Retrieval models results --- \textsc{bio-ml} track -- Rep is the representation type.} \label{tab:ir_bio-ml}
         \begin{tabular}{|l|c|l|r|r|r|r|r|r|r|r|r|}
             \hline
             \multirow{2}{*}{\textbf{Model}}  & \multirow{2}{*}{\textbf{Rep}}  & \multirow{2}{*}{\textbf{Task}} &  \multicolumn{3}{c|}{\textbf{$Top_k=5$ Results}} &  \multicolumn{3}{c|}{\textbf{$Top_k=10$ Results}} &  \multicolumn{3}{c|}{\textbf{$Top_k=20$ Results}}\\
             \cline{4-12}
              & & & Prec & Rec & F1& Prec & Rec & F1& Prec & Rec & F1 \\
             \hline
    	Ada  & C & ncit-doid.disease  & 5.47 & 91.91 & 10.32 & 2.8 & 94.3 & 5.45 & 1.43 & 95.92 & 2.81\\
	sentence-BERT  & C & ncit-doid.disease  & 5.37 & 90.25 & 10.13 & 2.74 & 92.23 & 5.33 & 1.4 & 93.85 & 2.75\\
	SPECTER2  & C & ncit-doid.disease  & 5.4 & 90.74 & 10.18 & 2.76 & 92.83 & 5.36 & 1.41 & 94.6 & 2.77\\
	TFIDF  & C & ncit-doid.disease  & 5.41 & 81.2 & 10.15 & 2.95 & 84.96 & 5.69 & 1.61 & 87.73 & 3.16\\
	\hline
	Ada  & C & omim-ordo.disease  & 5.62 & 72.83 & 10.43 & 2.93 & 76.05 & 5.65 & 1.52 & 78.66 & 2.98\\
	sentence-BERT  & C & omim-ordo.disease  & 5.51 & 71.49 & 10.24 & 2.89 & 74.95 & 5.57 & 1.49 & 77.32 & 2.93\\
	SPECTER2  & C & omim-ordo.disease  & 5.47 & 70.89 & 10.15 & 2.84 & 73.72 & 5.47 & 1.48 & 76.7 & 2.9\\
	TFIDF  & C & omim-ordo.disease  & 5.56 & 69.44 & 10.3 & 2.97 & 73.07 & 5.71 & 1.58 & 76.08 & 3.09\\
	\hline
	Ada  & C & snomed-fma.body  & 3.4 & 80.54 & 6.52 & 1.81 & 85.72 & 3.54 & 0.94 & 89.14 & 1.86\\
	sentence-BERT  & C & snomed-fma.body  & 3.15 & 74.66 & 6.04 & 1.67 & 79.37 & 3.28 & 0.87 & 82.87 & 1.73\\
	SPECTER2  & C & snomed-fma.body  & 2.22 & 52.63 & 4.26 & 1.29 & 60.98 & 2.52 & 0.72 & 68.61 & 1.43\\
	TFIDF  & C & snomed-fma.body  & 1.3 & 30.29 & 2.49 & 0.8 & 37.31 & 1.57 & 0.54 & 50.32 & 1.07\\
	\hline
	Ada  & C & snomed-ncit.neoplas  & 2.74 & 82.62 & 5.3 & 1.43 & 86.65 & 2.82 & 0.74 & 89.04 & 1.46\\
	sentence-BERT  & C & snomed-ncit.neoplas  & 2.64 & 79.65 & 5.11 & 1.38 & 83.39 & 2.72 & 0.71 & 86.2 & 1.42\\
	SPECTER2  & C & snomed-ncit.neoplas  & 2.6 & 78.55 & 5.04 & 1.37 & 82.65 & 2.69 & 0.72 & 86.38 & 1.42\\
	TFIDF  & C & snomed-ncit.neoplas  & 2.21 & 66.11 & 4.27 & 1.18 & 70.27 & 2.32 & 0.63 & 74.37 & 1.24\\
	\hline
	Ada  & C & snomed-ncit.pharm  & 3.75 & 95.31 & 7.22 & 1.89 & 96.16 & 3.71 & 0.95 & 96.95 & 1.89\\
	sentence-BERT  & C & snomed-ncit.pharm  & 3.65 & 92.87 & 7.03 & 1.84 & 93.73 & 3.62 & 0.93 & 94.55 & 1.84\\
	SPECTER2  & C & snomed-ncit.pharm  & 3.52 & 89.49 & 6.77 & 1.79 & 91.09 & 3.51 & 0.91 & 92.28 & 1.8\\
	TFIDF  & C & snomed-ncit.pharm  & 2.89 & 73.39 & 5.57 & 1.82 & 88.78 & 3.57 & 0.98 & 89.68 & 1.94\\
	\hline
	sentence-BERT  & CC & ncit-doid.disease  & 4.67 & 78.57 & 8.82 & 2.45 & 82.52 & 4.77 & 1.27 & 85.64 & 2.51\\
	SPECTER2  & CC & ncit-doid.disease  & 4.81 & 80.86 & 9.08 & 2.56 & 86.06 & 4.97 & 1.34 & 90.25 & 2.64\\
	TFIDF  & CC & ncit-doid.disease  & 5.17 & 81.09 & 9.72 & 2.82 & 85.81 & 5.47 & 1.52 & 88.8 & 2.98\\
	\hline
	sentence-BERT  & CC & omim-ordo.disease  & 5.18 & 67.21 & 9.63 & 2.74 & 71.08 & 5.28 & 1.43 & 74.36 & 2.81\\
	SPECTER2  & CC & omim-ordo.disease  & 5.35 & 69.34 & 9.93 & 2.8 & 72.61 & 5.39 & 1.46 & 75.89 & 2.87\\
	TFIDF  & CC & omim-ordo.disease  & 5.5 & 69.5 & 10.19 & 2.93 & 73.21 & 5.64 & 1.55 & 76.05 & 3.04\\
	\hline
	sentence-BERT  & CC & snomed-fma.body  & 1.99 & 47.23 & 3.82 & 1.16 & 55.03 & 2.27 & 0.67 & 63.27 & 1.32\\
	SPECTER2  & CC & snomed-fma.body  & 1.58 & 37.49 & 3.03 & 0.95 & 45.29 & 1.87 & 0.56 & 52.99 & 1.11\\
	TFIDF  & CC & snomed-fma.body  & 1.62 & 38.01 & 3.11 & 0.99 & 46.4 & 1.94 & 0.58 & 54.22 & 1.15\\
	\hline
	sentence-BERT  & CC & snomed-ncit.neoplas  & 2.49 & 75.32 & 4.83 & 1.31 & 79.1 & 2.58 & 0.68 & 82.44 & 1.35\\
	SPECTER2  & CC & snomed-ncit.neoplas  & 2.51 & 75.87 & 4.86 & 1.33 & 80.18 & 2.61 & 0.7 & 84.07 & 1.38\\
	TFIDF  & CC & snomed-ncit.neoplas  & 2.2 & 65.9 & 4.25 & 1.17 & 70.35 & 2.31 & 0.63 & 74.74 & 1.24\\
	\hline
	sentence-BERT  & CC & snomed-ncit.pharm  & 3.57 & 90.75 & 6.87 & 1.81 & 91.87 & 3.54 & 0.91 & 92.97 & 1.81\\
	SPECTER2  & CC & snomed-ncit.pharm  & 3.39 & 86.15 & 6.52 & 1.73 & 87.75 & 3.39 & 0.87 & 88.92 & 1.73\\
	TFIDF  & CC & snomed-ncit.pharm  & 3.37 & 85.58 & 6.49 & 1.72 & 87.11 & 3.37 & 0.92 & 88.13 & 1.82\\
	\hline
	sentence-BERT  & CP & ncit-doid.disease  & 5.1 & 85.81 & 9.63 & 2.67 & 89.82 & 5.19 & 1.38 & 92.74 & 2.72\\
	SPECTER2  & CP & ncit-doid.disease  & 5.21 & 87.58 & 9.83 & 2.72 & 91.36 & 5.28 & 1.4 & 94.52 & 2.77\\
	TFIDF  & CP & ncit-doid.disease  & 4.91 & 79.66 & 9.25 & 2.67 & 85.0 & 5.17 & 1.45 & 89.46 & 2.85\\
	\hline
	sentence-BERT  & CP & omim-ordo.disease  & 5.43 & 70.44 & 10.09 & 2.86 & 74.07 & 5.5 & 1.49 & 77.05 & 2.92\\
	SPECTER2  & CP & omim-ordo.disease  & 5.28 & 68.42 & 9.8 & 2.81 & 72.83 & 5.41 & 1.47 & 76.24 & 2.88\\
	TFIDF  & CP & omim-ordo.disease  & 5.53 & 69.12 & 10.24 & 2.97 & 73.15 & 5.7 & 1.58 & 76.48 & 3.09\\
	\hline
	sentence-BERT  & CP & snomed-fma.body  & 2.68 & 63.45 & 5.13 & 1.49 & 70.53 & 2.91 & 0.81 & 76.67 & 1.6\\
	SPECTER2  & CP & snomed-fma.body  & 2.01 & 47.7 & 3.86 & 1.19 & 56.35 & 2.33 & 0.69 & 65.09 & 1.36\\
	TFIDF  & CP & snomed-fma.body  & 1.06 & 24.74 & 2.03 & 0.75 & 34.9 & 1.46 & 0.55 & 50.91 & 1.08\\
	\hline
	sentence-BERT  & CP & snomed-ncit.neoplas  & 2.46 & 74.37 & 4.77 & 1.31 & 79.07 & 2.58 & 0.68 & 82.57 & 1.36\\
	SPECTER2  & CP & snomed-ncit.neoplas  & 2.46 & 74.19 & 4.76 & 1.31 & 79.02 & 2.57 & 0.69 & 83.02 & 1.36\\
	TFIDF  & CP & snomed-ncit.neoplas  & 2.18 & 65.43 & 4.22 & 1.17 & 70.16 & 2.31 & 0.62 & 74.13 & 1.23\\
	\hline
	sentence-BERT  & CP & snomed-ncit.pharm  & 3.02 & 76.67 & 5.8 & 1.6 & 81.58 & 3.15 & 0.84 & 85.47 & 1.66\\
	SPECTER2  & CP & snomed-ncit.pharm  & 2.87 & 72.98 & 5.53 & 1.53 & 77.79 & 3.0 & 0.8 & 81.46 & 1.59\\
	TFIDF  & CP & snomed-ncit.pharm  & 2.24 & 56.9 & 4.31 & 1.42 & 72.2 & 2.79 & 0.81 & 82.1 & 1.6\\
	\hline
    \end{tabular}
\end{table}
